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The following errors have been published in this work:

Abstract results: The confidence intervals for early virological response (EVR) should be 1.06--1.19, not 1.60--1.19.

Introduction: The sentence beginning, 'Such parameters include rapid response rate...' should read, 'Such parameters include rapid response rate (RVR; HCV-RNA negative at week 4 of therapy),...'

Viral Response: The first sentence should read, 'Compared with PEG-IFN-α2b plus ribavirin, PEG-IFN-α2a plus ribavirin led to a higher EVR (RR = 1.12, 95% CI: 1.06--1.19, n = 6 trials; Figure 2A), a higher ETR (RR = 1.21, 95% CI: 1.14--1.28, n = 4 trials; Figure 2B), and a higher level of SVR (RR = 1.10, 95% CI: 1.02--1.18, n = 5 trials; Figure 2C).'

Adverse events: The last sentence of the first paragraph should read, 'Therefore, compared with the PEG-IFN-α2b group, the risk ratio of the discontinuation of treatment for safety reasons in the PEG-IFN-α2a group was 0.85 (95% CI: 0.52 to 1.38, n = 6; Figure 4).'

Discussion: The first sentence should be replaced with the following two sentences, 'In this meta-analysis, we demonstrated the regimen of PEG-IFN-α2a plus ribavirin led to slightly better rates of EVR, ETR, and SVR compared with the use of PEG-IFN-α2b plus ribavirin in patients with HCV infections.'

Discussion: In the second sentence of the sixth paragraph, two, not three trials reported adequate allocation sequence generation.

Discussion: The second-to-last sentence of the fourth-to-last paragraph should read, 'When assessing the SVR, it is not so obvious.

Discussion: The first sentence of the third-to-last paragraph should read,'Adverse events were observed less frequently among patients treated with PEG-IFN-α2a, though the numbers of patients that suffered from anemia, depression and rash were not significantly different in this treatment group'.

The legend for Table 1 should read: 'The basic characteristics of seven trials included in this study (1)'.

The legend for Table 2 should read: 'The basic characteristics of seven trials included in this study (2)'.

In Figure 1, the numbers 5, 12 and 469 should be replaced with 6, 13 and 468, respectively.
